A Case Report of Photosensitivity to Amisulpride

View This PDF

NB: This article is only available as a PDF.

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Amisulpride is a second-generation antipsychotic approved as monotherapy for treatment of refractory schizophrenia. 1 It acts with a unique pharmacologic profile that has preferential affinity for D2/D3 receptors and specificity for limbic rather than striatal structures. Very few side effects of amisulpride therapy, and none with a dermatologic nature, have been reported.2

Prim Care Companion J Clin Psychiatry 2007;9(2):153 [letter]

https://doi.org/10.4088/PCC.v09n0211f